Evidence map›Paper›PMID 36050610›Full record

ArticleSurgical endoscopy2023

A randomized controlled trial of an enhanced recovery after surgery protocol in patients undergoing laparoscopic sleeve gastrectomy.

Pavlos Papasavas, Richard L Seip, Tara McLaughlin, Ilene Staff, Stephen Thompson, Ifeoma Mogor, Jane Sweeney, Richard Gannon, Witold Waberski, Darren Tishler

Abstract readClinical Trial Protocol
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. The Art of Sleeve Gastrectomy.Journal of clinical medicine · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Pavlos PapasavasHartford Healthcare Surgical Weight Loss Center, Hartford Hospital, 80 Seymour Street, Hartford, CT, 06106, USA. pavlos.papasavas@hhchealth.org.
Richard L SeipHartford Healthcare Surgical Weight Loss Center, Hartford Hospital, 80 Seymour Street, Hartford, CT, 06106, USA.
Tara McLaughlinDepartment of Surgery, Hartford Hospital, Hartford, CT, 06102, USA.ORCID http://orcid.org/0000-0001-9841-9843
Ilene StaffHartford Healthcare Research Program, Hartford, CT, 06102, USA.
Stephen ThompsonHartford Healthcare Research Program, Hartford, CT, 06102, USA.
Ifeoma MogorHartford Healthcare Surgical Weight Loss Center, Hartford Hospital, 80 Seymour Street, Hartford, CT, 06106, USA.
Jane SweeneyHartford Healthcare Surgical Weight Loss Center, Hartford Hospital, 80 Seymour Street, Hartford, CT, 06106, USA.
Richard GannonPharmacy Department, Hartford Hospital, Hartford, CT, 06102, USA.
Witold WaberskiDepartment of Anesthesia, Hartford Hospital, Hartford, CT, 06102, USA.
Darren TishlerHartford Healthcare Surgical Weight Loss Center, Hartford Hospital, 80 Seymour Street, Hartford, CT, 06106, USA.
Hartford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe purpose of this study was to evaluate the effect of an enhanced recovery after surgery (ERAS) protocol on opioid and anti-emetic use, length of stay and safety after laparoscopic sleeve gastrectomy (LSG).

methodsPatients who underwent LSG between March 2018 and January 2019 at our accredited, high-volume bariatric surgery center were randomized to either standard of care (SOC) or ERAS. ERAS included a pre- and post-surgical medication regimen designed to reduce postoperative nausea, vomiting and pain. Outcomes included post-operative symptom scores, opioid use, anti-emetic use, time to achieve readiness for discharge (RFD) and inpatient and 30-day adverse events, readmissions and emergency department visits.

resultsThe final analysis included 130 patients, (SOC 65; ERAS 65). Groups did not differ on demographics or comorbidities. Relative to SOC, fewer ERAS patients utilized opioids in the hospital ward (72.3% vs. 95.4%; p < .001), peak pain scores were significantly lower, and median time to achieve RFD was shorter (28.0 h vs. 44.4 h; p = 0.001). More ERAS patients were discharged on post-operative day 1 (38.5% vs. 15.4%; p < .05). The overall use of rescue anti-emetic medications was not different between groups. Rates of postoperative 30-day events, readmissions, and emergency department visits did not differ between groups.

conclusionRelative to SOC, ERAS was associated with earlier discharge, lower pain scores, less frequent use of opioids and use in lower amounts after LSG with no differences in 30 day safety outcomes.

Indexed as

AntiemeticsEnhanced Recovery After SurgeryLaparoscopyAnalgesics, OpioidGastrectomyHumansLength of StayPainPostoperative Nausea and VomitingRandomized Controlled Trials as TopicRetrospective StudiesAnalgesics, OpioidAntiemeticsEnhanced recovery after surgeryLaparoscopic sleeve gastrectomyOutcomesRandomized controlled trial

Identifiers

PMID36050610
OpenAlexW4294091292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.